Canada: Re-Examination Process Stayed Pending Resolution Of Patent Infringement Action (Intellectual Property Weekly Abstracts - Week of June 26, 2017)


Re-examination process stayed pending resolution of patent infringement action

Camso Inc. v. Soucy International Inc., 2016 FC 1116

In this motion, Camso requested a stay of a request made by a law firm, Brouillette + Partners, to the Commissioner of Patents to re-examine one of Camso's patents, Canadian Patent 2,822,562 (the '562 Patent). The request claimed lack of novelty and obviousness of the '562 Patent.

Another patent, Canadian Patent  2,388,294 (the '294 Patent), owned by Camso and relating to the same technology, namely, tracks used on all-terrain vehicles, had been the subject of a request for re-examination previously. The Court noted that Camso did not respond to this request and a number of claims were cancelled following the re-examination of the '294 Patent. The day after the decision of the re-examination board in November 2014, Camso commenced a patent infringement action against the defendants, Soucy. During the course of the action, the Statement of Claim was amended to allege infringement of the '562 Patent.

After the claim was amended, Brouillette + Partners filed a request for re-examination of the '562 Patent. Camso responded to this re-examination. Thus, as noted by the Court, the infringement action and the re-examination process were ongoing at the same time.  Further, counsel for Soucy, the defendant in the action, appeared on the motion to stay the request for re-examination.

The parties debated whether the applicable test for determining the motion was that as set out in RJR-Macdonald Inc v Canada (AG), [1994] 1 SCR 311 or that set out in White v EBF Manufacturing Ltd., 2001 FCT 713. After reviewing the case law, the Court held "there could be no controversy with regard to the test to be applied in our case: those cited converge."

In conducting its analysis on the merits, the Court noted the similarities between the allegations raised in the re-examination process and the infringement action, namely, lack of novelty and obviousness. The Court held that it was in the interest of justice to allow the proceeding in the Federal Court to proceed on the basis that it would allow more substantial evidence to be considered as compared to the re-examination process. The Court also considered arguments relating to the harm to Brouillette + Partners if the re-examination was stayed, and to Camso if it were not stayed. The Court concluded that the interest of justice favours ordering the stay of the re-examination process.

Costs in the amount of $3000 were to be paid immediately to Camso.

Court grants new counsels' eyes only order where previous order interfered significantly with the solicitor-client relationship

Bard Peripheral Vascular Inc. v. W.L. Gore & Associates, Inc., 2017 FC 585

The Court granted an appeal of the Prothonotary's Order, allowing Bard's motion to amend provisions in an existing protective order to the designation of "Counsels' Eyes Only" ("Amended CEO Order").

In the underlying proceeding, Bard alleged that Gore has infringed the '519 Patent, entitled Prosthetic Vascular Graft; Gore counterclaimed that the '519 Patent is invalid. The inventor of the '519 Patent, Dr. Goldfarb, has previously testified before the Federal Court in a related Canadian litigation matter pertaining to the '519 Patent, and before courts in the United States in related litigation matters.

Gore brought a motion before the District Court to examine Dr. Goldfarb on the basis of Letters Rogatory issued from this Court in this action. The District Court issued a subpoena, which was successfully quashed on appeal on the basis that Dr. Goldfarb was medically unfit to be examined. The Medical Records and the Subpoena Order were designated as CEO by the District Court.

The Amended CEO Order at issue prevented Gore's trial counsel from showing the U.S. order quashing a subpoena, and Dr. David Goldfarb's medical information, to Gore's in-house counsel and outside experts. The Court agreed that the Prothonotary erred in fact and law in holding that the Amended CEO Order would not prejudice Gore. Gore stated that it plans to use the Medical Records to challenge the admissibility of the hearsay evidence of Dr. Goldfarb, after outside counsel is able to receive necessary and proper instructions from their in-house counsel. This is precluded by the amended Order.  The Court concluded that the Amended CEO Order was inappropriate because of its significant interference with the solicitor-client relationship and granted a new CEO Order, which allows Gore's in-house counsel access to the Subpoena Order and the Medical Records.


Trademark infringement and passing off found in respect of 9 marks — permanent injunction granted

Diageo Canada Inc. v. Heaven Hill Distilleries, Inc., 2017 FC 571

In this case, Diageo brought suit against Heaven Hill, alleging passing off and infringement of Diageo's trademarks associated with its CAPTAIN MORGAN rum products by Heaven Hill's ADMIRAL NELSON'S rum products.

Heaven Hill argued that Diageo's case was an abuse of process. However, the Court held that the evidence relied upon by Heaven Hill shows no collateral, extraneous, ulterior, improper or illicit purpose.  Furthermore, there was no other evidence before the Court to show that the action is anything other than one to enforce trademark rights.

Heaven Hill also argued latches and acquiescence as there was evidence of Diageo's knowledge of ADMIRAL NELSON'S products in Canada as early as 2009, and it ought to have known of the products as early as 2003, yet it waited over a decade to take action.  Heaven Hill argued that Diageo permitted the ADMIRAL NELSON brand to establish itself in the market, and as such, if successful, an injunction should not be the remedy.  Diageo argued that it was not aware of the brand until 2013, and took immediate action.  After weighing the evidence, the Court held that Diageo was not aware of the ADMIRAL NELSON'S brand prior to 2013, and was not estopped in the action by reason of acquiescence, latches or delay.  As a result of the date finding, the Court also held that Diageo's claims were not statute-barred.

The Court held that the allegation that some of Diageo's registrations were abandoned should also fail.  Heaven Hill raised the point at trial, that despite admissions in its pleadings and in the agreed statement of facts, it did not sell ADMIRAL NELSON'S rum in Canada.  The Court considered the evidence, and held that not to be the case.

In considering the allegations of passing off, the Court held that Diageo had established goodwill.  The Court found no evidence of intentional misrepresentation on the part of Heaven Hill.  However, the Court did find misrepresentation due to confusion, on the basis of survey evidence submitted by Diageo.  Thus, the Court held that Diageo established, on a balance of probabilities, that Heaven Hill contravened subsection 7(b) of the Act.  However, there was no evidence that the ADMIRAL NELSON products were substituted for CAPTAIN MORGAN products.  Thus the allegations under subsection 7(c) were dismissed.  The Court also held that the requisite damages for a passing off claim were present.

The Court then considered the trademark infringement allegations.  After considering each of the elements of the test for trademark infringement, the Court held that Heaven Hill's use of its character or label trademarks in association with ADMIRAL NELSON'S rum products infringes Diageo's exclusive rights in 9 registered trademarks.  Furthermore, this use was held to likely have the effect of depreciating the value of the goodwill attached to Diageo's trademarks.  Diageo was granted, inter alia, declarations of infringement of 9 trademarks, a permanent injunction, and delivery up of all ADMIRAL NELSON'S bottles in Canada.  Diageo was further granted damages and its costs.

Heaven Hill's counterclaim, including for an injunction restraining Diageo from making false and misleading statements about its products and business, was dismissed.

Adequate alternative remedies do not include different proceedings pursuant to different statutory provisions

McDowell v. Automatic Princess Holdings, LLC, 2017 FCA 126

The Federal Court of Appeal has clarified the law relating to what constitutes an adequate alternate remedy in the context of interlocutory decisions in trademark opposition proceedings.

This is an appeal from a decision of the Federal Court (2015 FC 980), that dismissed an application for judicial review of a decision of the Trade-marks Opposition Board (TMOB) to refuse to allow McDowell to amend her statement of opposition to the respondent's trademark application.  The Federal Court had found that McDowell had an adequate remedy available, such as an expungement proceeding.

The Court of Appeal reviewed the jurisprudence and discussed how a prior decision of the Federal Court, Indigo Books & Music Inc. v. C. & J. Clark International Ltd., 2010 FC 859, held that an adequate alternate remedy could be one that exists outside of the framework of the opposition proceedings.  This decision was expressly overturned, finding that: 

[R]ecourse to the courts before the remedies provided in the administrative process have been exhausted is not justified. There is no ambiguity on this point. The fact that a different proceeding, pursuant to a different statutory provision, might produce the same result does not engage the doctrine of adequate alternate remedy. The objective is to avoid fragmenting administrative processes that already provide for a form of review. It is not to force litigants into different proceedings to obtain redress.

On this basis, the Court reviewed the TMOB's decision to refuse to allow McDowell to amend her statement of opposition.  That decision was not found to be reasonable.  While the amendment was sought late in the proceeding, the Court held that this is only a factor to be considered and where any prejudice caused by the delay can be remedied by allowing the other party additional time, it ought not to be a determinative factor.

The matter was returned to the TMOB with a direction that McDowell's application to amend her statement of opposition is to be allowed on such terms as are necessary to do justice between the parties.

No error was made in finding the trade name TIME DEVELOPMENT GROUP confusing with the registered mark TIMES GROUP CORPORATION

Time Development Group Inc. v. Times Group Corporation, 2017 FCA 125

The appellant Time Development Group Inc. was unsuccessful in its bid to overturn a prior decision finding its tradename, TIME DEVELOPMENT GROUP had infringed a registered trademark TIMES GROUP CORPORATION (2016 FC 1075, our summary here).  The appellants had been enjoined from using its tradenames or any confusingly similar variants.

The Court of Appeal first considered whether the registered mark had been used by anyone other than the owner, such that it was not distinctive.  The Federal Court had made a factual finding that the mark was not used by anyone other than the registered owner, and this finding was not overturned on appeal.  A second argument regarding the coexistence and use of similar tradenames and trademarks was also unsuccessful in showing a lack of distinctiveness.

As to confusion, the Court of Appeal was also not swayed that a palpable and overriding error was made.  The Federal Court found that there is a very strong resemblance between the registered trademark TIMES GROUP CORPORATION and the tradename TIME DEVELOPMENT GROUP.  This included the fact that the mark and name are used in similar businesses and in the same vicinity.  Namely, all of the parties are involved in real estate development and management, and their businesses are focused on the Chinese Canadian community in the Greater Toronto Area.

The Federal Court further noted a striking resemblance when the names are written in Chinese, because the singular and plural of TIME are the same.

After holding that there were no errors made with respect to the confusion analysis, the appeal was dismissed with costs.


AstraZeneca Canada Inc., AstraZeneca Aktiebolag, AstraZeneca UK Limited v. Apotex Inc., Apotex Pharmachem Inc. (Federal Court of Appeal) (Civil) (By leave) (Court Docket #36654)

The Supreme Court announced that judgment in the AstraZeneca's appeal will be delivered on Friday, June 30, 2017.

About BLG

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on

Click to Login as an existing user or Register so you can print this article.

In association with
Related Video
Up-coming Events Search
Font Size:
Mondaq on Twitter
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).
Email Address
Company Name
Confirm Password
Mondaq Topics -- Select your Interests
 Law Performance
 Law Practice
 Media & IT
 Real Estate
 Wealth Mgt
Asia Pacific
European Union
Latin America
Middle East
United States
Worldwide Updates
Mondaq Ltd requires you to register and provide information that personally identifies you, including what sort of information you are interested in, for three primary purposes:
  • To allow you to personalize the Mondaq websites you are visiting.
  • To enable features such as password reminder, newsletter alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our information providers who provide information free for your use.
  • Mondaq (and its affiliate sites) do not sell or provide your details to third parties other than information providers. The reason we provide our information providers with this information is so that they can measure the response their articles are receiving and provide you with information about their products and services.
    If you do not want us to provide your name and email address you may opt out by clicking here
    If you do not wish to receive any future announcements of products and services offered by Mondaq you may opt out by clicking here

    Terms & Conditions and Privacy Statement (the Website) is owned and managed by Mondaq Ltd and as a user you are granted a non-exclusive, revocable license to access the Website under its terms and conditions of use. Your use of the Website constitutes your agreement to the following terms and conditions of use. Mondaq Ltd may terminate your use of the Website if you are in breach of these terms and conditions or if Mondaq Ltd decides to terminate your license of use for whatever reason.

    Use of

    You may use the Website but are required to register as a user if you wish to read the full text of the content and articles available (the Content). You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these terms & conditions or with the prior written consent of Mondaq Ltd. You may not use electronic or other means to extract details or information about’s content, users or contributors in order to offer them any services or products which compete directly or indirectly with Mondaq Ltd’s services and products.


    Mondaq Ltd and/or its respective suppliers make no representations about the suitability of the information contained in the documents and related graphics published on this server for any purpose. All such documents and related graphics are provided "as is" without warranty of any kind. Mondaq Ltd and/or its respective suppliers hereby disclaim all warranties and conditions with regard to this information, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. In no event shall Mondaq Ltd and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use or performance of information available from this server.

    The documents and related graphics published on this server could include technical inaccuracies or typographical errors. Changes are periodically added to the information herein. Mondaq Ltd and/or its respective suppliers may make improvements and/or changes in the product(s) and/or the program(s) described herein at any time.


    Mondaq Ltd requires you to register and provide information that personally identifies you, including what sort of information you are interested in, for three primary purposes:

    • To allow you to personalize the Mondaq websites you are visiting.
    • To enable features such as password reminder, newsletter alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
    • To produce demographic feedback for our information providers who provide information free for your use.

    Mondaq (and its affiliate sites) do not sell or provide your details to third parties other than information providers. The reason we provide our information providers with this information is so that they can measure the response their articles are receiving and provide you with information about their products and services.

    Information Collection and Use

    We require site users to register with Mondaq (and its affiliate sites) to view the free information on the site. We also collect information from our users at several different points on the websites: this is so that we can customise the sites according to individual usage, provide 'session-aware' functionality, and ensure that content is acquired and developed appropriately. This gives us an overall picture of our user profiles, which in turn shows to our Editorial Contributors the type of person they are reaching by posting articles on Mondaq (and its affiliate sites) – meaning more free content for registered users.

    We are only able to provide the material on the Mondaq (and its affiliate sites) site free to site visitors because we can pass on information about the pages that users are viewing and the personal information users provide to us (e.g. email addresses) to reputable contributing firms such as law firms who author those pages. We do not sell or rent information to anyone else other than the authors of those pages, who may change from time to time. Should you wish us not to disclose your details to any of these parties, please tick the box above or tick the box marked "Opt out of Registration Information Disclosure" on the Your Profile page. We and our author organisations may only contact you via email or other means if you allow us to do so. Users can opt out of contact when they register on the site, or send an email to with “no disclosure” in the subject heading

    Mondaq News Alerts

    In order to receive Mondaq News Alerts, users have to complete a separate registration form. This is a personalised service where users choose regions and topics of interest and we send it only to those users who have requested it. Users can stop receiving these Alerts by going to the Mondaq News Alerts page and deselecting all interest areas. In the same way users can amend their personal preferences to add or remove subject areas.


    A cookie is a small text file written to a user’s hard drive that contains an identifying user number. The cookies do not contain any personal information about users. We use the cookie so users do not have to log in every time they use the service and the cookie will automatically expire if you do not visit the Mondaq website (or its affiliate sites) for 12 months. We also use the cookie to personalise a user's experience of the site (for example to show information specific to a user's region). As the Mondaq sites are fully personalised and cookies are essential to its core technology the site will function unpredictably with browsers that do not support cookies - or where cookies are disabled (in these circumstances we advise you to attempt to locate the information you require elsewhere on the web). However if you are concerned about the presence of a Mondaq cookie on your machine you can also choose to expire the cookie immediately (remove it) by selecting the 'Log Off' menu option as the last thing you do when you use the site.

    Some of our business partners may use cookies on our site (for example, advertisers). However, we have no access to or control over these cookies and we are not aware of any at present that do so.

    Log Files

    We use IP addresses to analyse trends, administer the site, track movement, and gather broad demographic information for aggregate use. IP addresses are not linked to personally identifiable information.


    This web site contains links to other sites. Please be aware that Mondaq (or its affiliate sites) are not responsible for the privacy practices of such other sites. We encourage our users to be aware when they leave our site and to read the privacy statements of these third party sites. This privacy statement applies solely to information collected by this Web site.

    Surveys & Contests

    From time-to-time our site requests information from users via surveys or contests. Participation in these surveys or contests is completely voluntary and the user therefore has a choice whether or not to disclose any information requested. Information requested may include contact information (such as name and delivery address), and demographic information (such as postcode, age level). Contact information will be used to notify the winners and award prizes. Survey information will be used for purposes of monitoring or improving the functionality of the site.


    If a user elects to use our referral service for informing a friend about our site, we ask them for the friend’s name and email address. Mondaq stores this information and may contact the friend to invite them to register with Mondaq, but they will not be contacted more than once. The friend may contact Mondaq to request the removal of this information from our database.


    From time to time Mondaq may send you emails promoting Mondaq services including new services. You may opt out of receiving such emails by clicking below.

    *** If you do not wish to receive any future announcements of services offered by Mondaq you may opt out by clicking here .


    This website takes every reasonable precaution to protect our users’ information. When users submit sensitive information via the website, your information is protected using firewalls and other security technology. If you have any questions about the security at our website, you can send an email to

    Correcting/Updating Personal Information

    If a user’s personally identifiable information changes (such as postcode), or if a user no longer desires our service, we will endeavour to provide a way to correct, update or remove that user’s personal data provided to us. This can usually be done at the “Your Profile” page or by sending an email to

    Notification of Changes

    If we decide to change our Terms & Conditions or Privacy Policy, we will post those changes on our site so our users are always aware of what information we collect, how we use it, and under what circumstances, if any, we disclose it. If at any point we decide to use personally identifiable information in a manner different from that stated at the time it was collected, we will notify users by way of an email. Users will have a choice as to whether or not we use their information in this different manner. We will use information in accordance with the privacy policy under which the information was collected.

    How to contact Mondaq

    You can contact us with comments or queries at

    If for some reason you believe Mondaq Ltd. has not adhered to these principles, please notify us by e-mail at and we will use commercially reasonable efforts to determine and correct the problem promptly.

    By clicking Register you state you have read and agree to our Terms and Conditions